AstraZeneca Pharma India balance sheet

As of Mar 2026

Total assets: ₹1,989cr+31.0% on Mar 2025
Shareholders' equity: ₹873cr+13.3% on Mar 2025
Total debt: ₹0.0crNo figure a year before
Cash and investments: ₹448cr−16.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	117	63.6	60.4	68.9
	0.0	0.0	0.3	1.3
	0.0	0.0	4.2	0.0
	0.0	0.0	2.1	0.0
	0.0	0.7	0.0	0.0
	0.0	0.0	52.6	0.0
	0.0	0.1	0.3	0.9
	13.4	8.0	2.5	3.1
	13.4	8.1	55.4	4.0
	37.8	41.6	21.2	20.7
	80.5	61.8	1.7	3.0
	249	176	145	97.8
	1,027	549	228	190
	214	185	153	108
	448	536	506	500
	0.9	0.6	0.3	0.1
	0.0	0.3	0.1	0.1
	8.7	15.8	27.9	10.6
	671	738	687	619
	33.8	56.2	17.9	26.6
	1,732	1,342	933	887
	7.7	0.0	—	0.0
	1,989	1,518	1,078	985
Equity
	5.0	5.0	5.0	5.0
	868	765	707	584
	873	770	712	589
	873	770	712	589
Liabilities
	96.8	29.5	0.0	3.7
	96.8	29.5	2.8	3.7
	15.8	6.3	6.2	8.6
	21.9	9.0	0.0	0.0
	135	44.8	9.0	12.3
	783	456	198	228
	36.7	31.6	31.0	33.9
	819	488	229	262
	55.9	107	43.4	41.7
	5.4	10.6	6.7	2.4
	101	98.0	77.7	78.1
	982	703	357	384
	1,116	748	366	396
	1,989	1,518	1,078	985
Assets — additional as-filed lines
	0.0	0.0	0.0	51.6
Liabilities — additional as-filed lines
	0.0	0.0	2.8	0.0
Trade payables — MSME split
	2.0	2.5	—	—
	781	454	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ASTRAZEN₹6,237.00

AstraZeneca Pharma India Limited

· Pharma & Health

₹ CrorePeersSANOFICONR PGHL SANOFI SENORES INNOVACAP MOREPENLAB IOLCP FDCMcap ₹15,593 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	68.9	60.4	63.6	117.5	117.5
+ Capital Work-in-Progress	1.3	0.3	0.0	0.0	0.0
+ Investment Property	0.0	4.2	0.0	0.0	0.0
+ Goodwill	0.0	2.1	0.0	0.0	0.0
+ Other Intangibles	0.0	0.0	0.7	0.0	0.0
+ Non-current Investments	0.0	52.6	0.0	0.0	0.0
+ Long-term Loans	0.9	0.3	0.1	0.0	0.0
+ Other Non-current Financial Assets	3.1	2.5	8.0	13.4	13.4
Non-current Financial Assets	4.0	55.4	8.1	13.4	13.4
+ Deferred Tax Assets	20.7	21.2	41.6	37.8	37.8
+ Other Non-current Assets	3.0	1.7	61.8	80.5	80.5
Total Non-current Assets	97.8	145.3	175.8	249.2	249.2
Current Assets
+ Inventories	190.2	227.9	548.5	1,027.3	1,027.3
+ Trade Receivables	107.5	153.1	184.9	213.7	213.7
+ Cash & Cash Equivalents	500.3	505.6	536.1	447.7	447.7
+ Other Bank Balances	0.1	0.3	0.6	0.9	0.9
+ Short-term Loans	0.1	0.1	0.3	0.0	0.0
+ Other Current Financial Assets	10.6	27.9	15.8	8.7	8.7
Current Financial Assets	618.7	686.9	737.7	671.0	671.0
+ Other Current Assets	26.6	17.9	56.2	33.8	33.8
Total Current Assets	887.1	932.7	1,342.4	1,732.2	1,732.2
+ Assets Held for Sale	0.0	—	0.0	7.7	7.7
Total Assets	984.9	1,078.0	1,518.1	1,989.1	1,989.1
Equity
+ Equity Share Capital	5.0	5.0	5.0	5.0	5.0
+ Other Equity / Reserves	583.7	706.9	765.4	867.8	867.8
Equity — Owners of Parent	588.7	711.9	770.4	872.8	872.8
Total Equity	588.7	711.9	770.4	872.8	872.8
Liabilities
+ Other Non-current Financial Liab	3.7	0.0	29.5	96.8	96.8
Non-current Financial Liabilities	3.7	2.8	29.5	96.8	96.8
+ Provisions — Non-current	8.6	6.2	6.3	15.8	15.8
+ Other Non-current Liabilities	0.0	0.0	9.0	21.9	21.9
Non-current Liabilities	12.3	9.0	44.8	134.5	134.5
+ Trade Payables	227.9	198.3	456.3	782.7	782.7
+ Other Current Financial Liab	33.9	31.0	31.6	36.7	36.7
Current Financial Liabilities	261.8	229.3	487.9	819.4	819.4
+ Provisions — Current	41.7	43.4	106.5	55.9	55.9
+ Current Tax Liabilities	2.4	6.7	10.6	5.4	5.4
+ Other Current Liabilities	78.1	77.7	98.0	101.1	101.1
Current Liabilities	383.9	357.1	703.0	981.8	981.8
Total Liabilities	396.2	366.1	747.8	1,116.3	1,116.3
Total Equity & Liabilities	984.9	1,078.0	1,518.1	1,989.1	1,989.1
Assets — additional as-filed lines
+ Current Tax Assets	51.6	0.0	0.0	0.0	0.0
Liabilities — additional as-filed lines
+ Trade Payables — Non-current	0.0	2.8	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	2.5	2.0	2.0
+ Dues to Other Creditors — Current	—	—	453.8	780.7	780.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.